down arrow

Ganga Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE615T01017
  • NSEID:
  • BSEID: 539680
INR
11.18
1.01 (9.93%)
BSENSE

Apr 11, 11:54 AM

BSE+NSE Vol: 32.0 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

11.1811.18

52 Week

9.2527.10
Valuation
Technical
Day's Volume

CASH

32.0 k (0.00%) Volume

Shareholding (Sep 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

56.02%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 5 Cr (Micro Cap)

stock-summary
P/E

5.00

stock-summary
Industry P/E

24

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.17

stock-summary
Return on Equity

0.77%

stock-summary
Price to Book

0.76

Revenue and Profits (1 Year):
Net Sales:
1 Cr
(Quarterly Results - Sep 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-28.93%
0%
-28.93%
1 Year
-52.43%
0%
-52.43%
2 Years
-19.74%
0%
-19.74%
3 Years
9.07%
0%
9.07%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Ganga Pharma. for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-4.00%
EBIT Growth (5y)
-8.54%
EBIT to Interest (avg)
0.05
Debt to EBITDA (avg)
2.04
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.45
Tax Ratio
20.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.95%
ROE (avg)
1.32%
Valuation key factors
Factor
Value
P/E Ratio
5
Industry P/E
24
Price to Book Value
0.76
EV to EBIT
6.00
EV to EBITDA
6.00
EV to Capital Employed
0.80
EV to Sales
2.19
PEG Ratio
0.99
Dividend Yield
NA
ROCE (Latest)
0.13%
ROE (Latest)
0.77%
Tecnicals key factors
Indicator
Weekly
Monthly
Icon
Technical indicator has not been calculated since the stock has been active for a short period
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Sharma Bharat B (30.12%)

Highest Public shareholder

Lenus Finvest Private Limited (7.75%)

Individual Investors Holdings

35.23%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.31",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.12",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.09",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.02",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-9.16%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -7.75% vs 7.58% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -33.33% vs 50.00% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.31",
          "val2": "1.42",
          "chgp": "-7.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.12",
          "val2": "0.01",
          "chgp": "-1,300.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.09",
          "val2": "0.09",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.02",
          "val2": "0.03",
          "chgp": "-33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-9.16%",
          "val2": "0.70%",
          "chgp": "-9.86%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Sep 2024 is -1.13% vs 3.91% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Sep 2024 is -20.00% vs 150.00% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.63",
          "val2": "2.66",
          "chgp": "-1.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.07",
          "val2": "-0.05",
          "chgp": "-40.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.18",
          "val2": "0.21",
          "chgp": "-14.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.04",
          "val2": "0.05",
          "chgp": "-20.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2.66%",
          "val2": "-1.88%",
          "chgp": "-0.78%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 5.79% vs 4.02% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 25.00% vs 0.00% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.74",
          "val2": "2.59",
          "chgp": "5.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.06",
          "val2": "0.01",
          "chgp": "500.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.18",
          "val2": "0.19",
          "chgp": "-5.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.05",
          "val2": "0.04",
          "chgp": "25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.19%",
          "val2": "0.39%",
          "chgp": "1.80%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Sep'24 - YoYstock-summary
Sep'24
Change(%)
Net Sales
1.31
NA
NA
Operating Profit (PBDIT) excl Other Income
-0.12
NA
NA
Interest
0.09
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
0.02
NA
NA
Operating Profit Margin (Excl OI)
-9.16%
NA%
NA
Values in Rs Cr.
stock-summary Compare with Peers
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Mar'24
Change(%)
Net Sales
1.31
1.42
-7.75%
Operating Profit (PBDIT) excl Other Income
-0.12
0.01
-1,300.00%
Interest
0.09
0.09
Exceptional Items
0.00
0.00
Standalone Net Profit
0.02
0.03
-33.33%
Operating Profit Margin (Excl OI)
-9.16%
0.70%
-9.86%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -7.75% vs 7.58% in Mar 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is -33.33% vs 50.00% in Mar 2024

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'24
Change(%)
Net Sales
2.63
2.66
-1.13%
Operating Profit (PBDIT) excl Other Income
-0.07
-0.05
-40.00%
Interest
0.18
0.21
-14.29%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.04
0.05
-20.00%
Operating Profit Margin (Excl OI)
-2.66%
-1.88%
-0.78%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Sep 2024 is -1.13% vs 3.91% in Sep 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Sep 2024 is -20.00% vs 150.00% in Sep 2024

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
2.74
2.59
5.79%
Operating Profit (PBDIT) excl Other Income
0.06
0.01
500.00%
Interest
0.18
0.19
-5.26%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.05
0.04
25.00%
Operating Profit Margin (Excl OI)
2.19%
0.39%
1.80%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 5.79% vs 4.02% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 25.00% vs 0.00% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Ganga Pharmaceuticals Ltd stock-summary
stock-summary
Ganga Pharmaceuticals Ltd
Micro Cap
Pharmaceuticals & Drugs
Ganga Pharmaceuticals Ltd was incorporated as a Public Limited Company in Aug.'94 and promoted by Brij Mohan Sharma. he Company is engaged in the business of manufacturing & trading in Pharmaceuticals & allied products (Ayurveda). In Apr.'95, the company took over Ganga pharmaceuticals, a proprietory concern (owned by the same promoter), which was manufacturing and marketing ayurvedic products since the last two decades.
Company Coordinates stock-summary
Company Details
Gangatat Dhanvantri Marg, Gopcharpada Virar (E) Palghar Maharashtra : 401305
stock-summary
Tel: 91-250-6098333/444
stock-summary
http://www.ayurvedganga.com
stock-summary
ayurvedganga@gmail.com
Registrar Details
Karvy Computershare Pvt Ltd., Karvy Selenium, Tower-B Plot No 31 & 32, Survey No 116/22, 115/24, 115/25, Financial District, Nanakramguda, Serilingampally, Mandal Ranga Reddy Dist, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."